Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

LENZ Therapeutics (LENZ) Leases (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Leases for 4 consecutive years, with $734000.0 as the latest value for Q4 2025.

  • Quarterly Leases fell 45.14% to $734000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $734000.0 through Dec 2025, down 45.14% year-over-year, with the annual reading at $734000.0 for FY2025, 45.14% down from the prior year.
  • Leases for Q4 2025 was $734000.0 at LENZ Therapeutics, down from $847000.0 in the prior quarter.
  • The five-year high for Leases was $15.8 million in Q2 2023, with the low at $578000.0 in Q1 2024.
  • Average Leases over 4 years is $4.9 million, with a median of $1.7 million recorded in 2024.
  • The sharpest move saw Leases skyrocketed 85.32% in 2023, then crashed 89.1% in 2024.
  • Over 4 years, Leases stood at $5.6 million in 2022, then skyrocketed by 136.47% to $13.2 million in 2023, then plummeted by 89.86% to $1.3 million in 2024, then plummeted by 45.14% to $734000.0 in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $734000.0, $847000.0, and $959000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.